Schroders Global Innovation Trust participates in iOnctura €80m Series B

Schroders Capital Global Innovation Trust invested an additional €1.7m, about £1.4m, in Dutch oncology company iOnctura as part of an €80m Series B financing led by Syncona. The €80m total round was not solely Schroders capital.